Attached files
| file | filename |
|---|---|
| EX-31.2 - EX-31.2 - AVITA Medical, Inc. | d80602dex312.htm |
| EX-31.1 - EX-31.1 - AVITA Medical, Inc. | d80602dex311.htm |
| EX-21.1 - EX-21.1 - AVITA Medical, Inc. | d80602dex211.htm |
| EX-14.1 - EX-14.1 - AVITA Medical, Inc. | d80602dex141.htm |
| 10-K - 10-K - AVITA Medical, Inc. | d80602d10k.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code), each of the undersigned officers of Avita Therapeutics, Inc. (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Annual Report on Form 10-K for the year ended June 30, 2020 of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Dated: August 27, 2020 | /s/ Michael Perry | |||||
| Name: | Michael Perry | |||||
| Title: | President and Chief Executive Officer | |||||
| Dated: August 27, 2020 | /s/ David McIntyre | |||||
| Name: | David McIntyre | |||||
| Title: | Chief Financial Officer | |||||
The foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) and is not being filed as part of the Form 10-K or as a separate disclosure document.